Canfield Dennis V, Salazar Guillermo J, Lewis Russell J, Whinnery James E
Civil Aerospace Medical Institute, Federal Aviation Administration, Oklahoma City, OK 73125-5006, USA.
Aviat Space Environ Med. 2006 Nov;77(11):1171-3.
Federal Aviation Administration (FAA) regulations require pilots to report all medications and medical conditions for review and consideration as to the overall suitability of the pilot for flight activities.
Specimens were collected by local pathologists from aviation accidents and sent to the Bioaeronautical Sciences Research Laboratory for analysis. The results of such tests were entered into the Forensic Case Management System. This database was searched to identify all pilots found positive for medications used to treat cardiovascular, psychological, or neurological conditions over the period January 1, 1993, through December 31, 2003.
Toxicological evaluations were performed on 4143 pilots. Psychotropic drugs were found in 223 pilots. Cardiovascular medications were found in 149 pilots. Neurological medications were found in 15 pilots. Pilots reported psychological conditions in 14 of the 223 pilots found positive for psychotropic drugs. Only 1 of the 14 pilots reporting a psychological condition to the FAA reported the psychotropic medication found after the accident. Cardiovascular disease was reported by 69 of the pilots found with cardiovascular drugs in their system. Cardiovascular medications found in the pilots were reported by 29 of the 69 pilots reporting a cardiovascular condition. Only 1 of the 15 pilots reported having a neurological condition to the FAA; none of the pilots found with neurological medications reported the medication.
Toxicology successfully identified 93% of the medications reported by the pilots. Pilots involved in fatal accidents taking psychotropic or neurological medications rarely reported the medication or their underlying medical condition to the FAA.
美国联邦航空管理局(FAA)规定,飞行员必须报告所有药物和医疗状况,以便对其飞行活动的整体适宜性进行审查和考量。
当地病理学家从航空事故中采集样本,并送往生物航空科学研究实验室进行分析。这些测试结果被录入法医案件管理系统。对该数据库进行搜索,以识别在1993年1月1日至2003年12月31日期间,所有被检测出使用治疗心血管、心理或神经疾病药物呈阳性的飞行员。
对4143名飞行员进行了毒理学评估。在223名飞行员体内发现了精神药物。在149名飞行员体内发现了心血管药物。在15名飞行员体内发现了神经药物。在223名被检测出精神药物呈阳性的飞行员中,有14名报告有心理状况。在向FAA报告心理状况的14名飞行员中,只有1名报告了事故后发现的精神药物。在其系统中发现心血管药物的飞行员中有69名报告患有心血管疾病。在报告患有心血管疾病的69名飞行员中,有29名报告了在其体内发现的心血管药物。在15名飞行员中,只有1名向FAA报告患有神经疾病;在被检测出使用神经药物的飞行员中,没有人报告使用了该药物。
毒理学成功识别出飞行员报告的93%的药物。涉及致命事故且服用精神或神经药物的飞行员很少向FAA报告所服用的药物或其潜在的医疗状况。